-+ 0.00%
-+ 0.00%
-+ 0.00%

C4 Therapeutics Q3 EPS $(0.44) Misses $(0.40) Estimate, Sales $11.230M Beat $6.280M Estimate

Benzinga·11/06/2025 12:10:12
Listen to the news
C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.40) by 10.28 percent. This is a 25.71 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $11.230 million which beat the analyst consensus estimate of $6.280 million by 78.82 percent. This is a 26.90 percent decrease over sales of $15.362 million the same period last year.